Patent ID: 9623090
Date: 2017-04-18
CPC Classifications: A61K,A61P,C12Y,G01N

Claim:
1. A method of treating a neurological parameter or a neurological symptom associated with Gaucher Type III disease in a subject with Gaucher Type III disease, the method comprising (i) administering a glucocerebrosidase enzyme replacement therapy by intravenous infusion to the subject over a period of less than 2 hours and (ii) evaluating whether the neurological parameter or the neurological symptom has changed, wherein the neurological parameter or the neurological symptom is selected from the group consisting of eye movement parameters, hearing parameters, abnormal brainstem auditory evoked potentials, seizures, progressive myoclonic seizures, electroencephalogram (EEG) abnormalities, dementia, cognitive impairment, ataxia, loss of muscle coordination, and poor mobility.